Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 13, 2019
[ Fri, Dec 13th 2019
] - WOPRAI
[ Fri, Dec 13th 2019
] - WOPRAI
[ Fri, Dec 13th 2019
] - WOPRAI
Thu, December 12, 2019
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
Chris Schott Upgraded (BHC) to Buy and Increased Target to $38 on, Dec 12th, 2019
Chris Schott of JP Morgan, Upgraded "Bausch Health Companies Inc." (BHC) to Buy and Increased Target from $32 to $38 on, Dec 12th, 2019.
Chris has made no other calls on BHC in the last 4 months.
There is 1 other peer that has a rating on BHC. Out of the 1 peers that are also analyzing BHC, 0 agree with Chris's Rating of Hold.
This is the rating of the analyst that currently disagrees with Chris
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019
